Jan 13, 2021 / 03:50PM GMT
Tycho W. Peterson - JPMorgan Chase & Co, Research Division - Senior Analyst
All right. Good morning. We're going to kick it off here with Danaher. I'm Tycho Peterson from the life science team. Just a quick reminder before I turn it over to Rainer. If people have questions for the Q&A, please submit those through the website.
And with that, let me turn it over to Rainer.
Rainer M. Blair - Danaher Corporation - President, CEO & Director
Well, thank you, Tycho, and good morning. Good morning to everybody. Tycho, I've heard nothing but great things about the new format this year. And so congratulations to the organization that you've put together. And I certainly hope that in the future, we can get together again in person soon.
So why don't we move on here briefly to the next slide, where you see our forward-looking statements advisory, and that's for your reference. And then we'll go ahead and move to the next slide here, where I can quickly outline what I'll talk about today.
So first, I'll kick things off with the
Danaher Corp at JPMorgan Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot